283 related articles for article (PubMed ID: 19609063)
1. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement.
Komine M
J Pharmacol Sci; 2009 Jul; 110(3):260-4. PubMed ID: 19609063
[TBL] [Abstract][Full Text] [Related]
2. Keratinocytes: An Enigmatic Factor in Atopic Dermatitis.
Das P; Mounika P; Yellurkar ML; Prasanna VS; Sarkar S; Velayutham R; Arumugam S
Cells; 2022 May; 11(10):. PubMed ID: 35626720
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated Skin Inflammation is Similar in Severe Atopic Dermatitis Patients With or Without Filaggrin Mutation.
Dajnoki Z; Béke G; Mócsai G; Kapitány A; Gáspár K; Hajdu K; Emri G; Nagy B; Kovács I; Beke L; Dezső B; Szegedi A
Acta Derm Venereol; 2016 Jun; 96(5):645-50. PubMed ID: 26536977
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytes: innate immune cells in atopic dermatitis.
Chieosilapatham P; Kiatsurayanon C; Umehara Y; Trujillo-Paez JV; Peng G; Yue H; Nguyen LTH; Niyonsaba F
Clin Exp Immunol; 2021 Jun; 204(3):296-309. PubMed ID: 33460469
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of atopic dermatitis.
Mu Z; Zhao Y; Liu X; Chang C; Zhang J
Clin Rev Allergy Immunol; 2014 Oct; 47(2):193-218. PubMed ID: 24715253
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Atopic Dermatitis: Current Paradigm.
Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
[TBL] [Abstract][Full Text] [Related]
7. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK
PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675
[TBL] [Abstract][Full Text] [Related]
8. TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice.
Leyva-Castillo JM; Hener P; Jiang H; Li M
J Invest Dermatol; 2013 Jan; 133(1):154-63. PubMed ID: 22832486
[TBL] [Abstract][Full Text] [Related]
9. Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.
Zhu Y; Underwood J; Macmillan D; Shariff L; O'Shaughnessy R; Harper JI; Pickard C; Friedmann PS; Healy E; Di WL
J Allergy Clin Immunol; 2017 Nov; 140(5):1310-1322.e5. PubMed ID: 28238749
[TBL] [Abstract][Full Text] [Related]
10. (S)-(-)-blebbistatin O-benzoate has the potential to improve atopic dermatitis symptoms in NC/Nga mice by upregulating epidermal barrier function and inhibiting type 2 alarmin cytokine induction.
Sahara S; Ueno A; Wakita N; Iwai M; Uda J; Nakaoji K; Hamada K; Maeda A; Kaneda Y; Fujimoto M
PLoS One; 2024; 19(5):e0302781. PubMed ID: 38713650
[TBL] [Abstract][Full Text] [Related]
11. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
Kubo A; Nagao K; Amagai M
J Clin Invest; 2012 Feb; 122(2):440-7. PubMed ID: 22293182
[TBL] [Abstract][Full Text] [Related]
12. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.
Li M; Hener P; Zhang Z; Kato S; Metzger D; Chambon P
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11736-41. PubMed ID: 16880407
[TBL] [Abstract][Full Text] [Related]
13. Filaggrin mutations and atopy: consequences for future therapeutics.
Heimall J; Spergel JM
Expert Rev Clin Immunol; 2012 Feb; 8(2):189-97. PubMed ID: 22288457
[TBL] [Abstract][Full Text] [Related]
14. ΔNp63 controls a TLR3-mediated mechanism that abundantly provides thymic stromal lymphopoietin in atopic dermatitis.
Kubo T; Kamekura R; Kumagai A; Kawata K; Yamashita K; Mitsuhashi Y; Kojima T; Sugimoto K; Yoneta A; Sumikawa Y; Yamashita T; Sato N; Himi T; Ichimiya S
PLoS One; 2014; 9(8):e105498. PubMed ID: 25171086
[TBL] [Abstract][Full Text] [Related]
15. [The research for atopic dermatitis: up to date].
Yokozeki H
Nihon Rinsho; 2014 Aug; 72(8):1503-9. PubMed ID: 25167760
[TBL] [Abstract][Full Text] [Related]
16. Skin barrier function in atopic dermatitis.
Vickery BP
Curr Opin Pediatr; 2007 Feb; 19(1):89-93. PubMed ID: 17224668
[TBL] [Abstract][Full Text] [Related]
17. Basics and recent advances in the pathophysiology of atopic dermatitis.
Nakahara T; Kido-Nakahara M; Tsuji G; Furue M
J Dermatol; 2021 Feb; 48(2):130-139. PubMed ID: 33118662
[TBL] [Abstract][Full Text] [Related]
18. From atopic dermatitis to asthma: the atopic march.
Spergel JM
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):99-106; quiz 107-9, 117. PubMed ID: 20674819
[TBL] [Abstract][Full Text] [Related]
19. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.
Thyssen JP; Kezic S
J Allergy Clin Immunol; 2014 Oct; 134(4):792-9. PubMed ID: 25065719
[TBL] [Abstract][Full Text] [Related]
20. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
Kabashima K
J Dermatol Sci; 2013 Apr; 70(1):3-11. PubMed ID: 23473856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
